Medical Science Liaison; MSL​/Senior Medical Science Liaison; Sr. MSL), Oncology - Texas

Overview

At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai's human health care (hhc) mission. We are a growing pharmaceutical company breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world’s most widely‑used treatment for Alzheimer’s disease.

We are seeking highly‑motivated individuals who want to work in a fast‑paced environment and make a difference.

• Build relationships and demonstrate the clinical outcome and benefits of company products to thought leaders, medical groups, government agencies, key opinion leaders and health systems.
• Educate and demonstrate the benefits of key products to clinical professors, teaching‑hospital faculty, residents, and students.
• Provide medical information to internal/external health sources such as the sales force, outside health professionals, public, and government.
• Explore and identify sites for clinical trial in all stages of development.
• Coordinate continuing education workshops, seminars, and programs for graduate physicians, pharmacists, and scientists.
• Respond to unsolicited inquiries to establish and/or further the knowledge and understanding of marketed products.
• Act as the primary clinical/scientific resource to healthcare providers in the territory for information about disease state and Eisai’s product(s).
• Serve as a conduit for accurate and updated clinical, scientific and medical information between key opinion leaders and the company’s Medical Affairs and development groups.
• Establish, foster, cultivate and maintain peer relationships with KOLs.
• Share knowledge and participate in scientific exchanges with identified KOLs.
• Present clinical, scientific and economic data on Eisai products to population‑based decision‑makers.
• Support assigned professional congresses and lead congress coverage efforts.
• Identify and report key scientific, clinical and research insights from KOLs to Medical Affairs.
• Develop, implement and present plans to support Medical Affairs strategic direction for assigned territory.

• Maintain and demonstrate thorough and up‑to‑date knowledge of disease state, study methodology, clinical information, and product data.
• Demonstrate full knowledge of and ability to execute on approved medical platforms/strategies and MSL initiatives.
• Serve as technical/scientific subject matter resource to Eisai commercial personnel, if requested.
• Teach, coach and mentor new or less experienced MSLs; assist with supervision/performance evaluation; assume responsibility for special projects.

• Facilitate review and follow up of submitted Investigator‑Initiated Studies and assist with Eisai sponsored trials.
• Serve as primary contact to external investigators who submit IISs and provide recommendations for site selection and scientific expertise to investigators involved in company‑sponsored post‑marketing studies.

• Lead field medical efforts in support of Eisai’s collaboration and interactions with professional organizations/societies and advocacy groups, as required.

Requires an advanced, terminal Doctorate level (D‑level) degree in medical or health sciences (MD, PhD, Pharm

D, DPH, EdD).

• For MSL 0‑3 years of experience in the pharma/biotech industry clinical pharmacist/research/related experience in a scientific or clinical setting, preferably as MSL.
• For Sr. MSL, a minimum of 3 years MSL experience in Oncology/Hematology.
• Strong broad‑based scientific and pharmaceutical knowledge.
• Clinical trial development and drug launch experience is strongly preferred.
• Knowledge of treatment guidelines, clinical research processes, FDA regulations and OIG guidelines are required.
• Knowledge and experience within Eisai desired therapeutic area(s) and ability to communicate with confidence and accuracy across multiple disease states.
• Established relationships with key opinion leaders and knowledge of institutions in therapeutic areas of…